Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Mise à jour : Il y a 4 ans
Référence : NCT00861692

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to collect data on the clinical management of Argatroban in patients with suspected or confirmed heparin-induced thrombocytopenia Type II, with or without ongoing thrombosis who require parenteral antithrombotic therapy


Critère d'inclusion

  • Heparin-induced Thrombocytopenia Type II

Liens